Lengthening the lifespan of mighty humans with tiny probiotic Clostridium Butyricum: Probiotic Clostridium Butyricum CGMCC0313.1 may increase insulin sensitivity, slow down cardiac aging, and increase lifespan, via up-regulation of BubR1 and others longevity-promoting genes, 28/October/2018, 11.00 pm
A probiotic way to smother anxiety and depression: Probiotic lactobacillus reuteri decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 28/October/2018, 2.18 pm
October 28, 2018
A musical way to keep the cardiac diseases at bay-hard to believe though(that is not what science-based music thinks so): Music-based adjunctive Regenerative therapy for Cardiomyopathy: Music decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy, via up regulation of its target gene, 30/October/2018, 8.40 am
October 30, 2018What they say: Introduction:
A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston, USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July 2014 issue of the journal “EMBO”, by Prof Sinclair, North BJ, and others.
What we say:
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Lengthening the lifespan of mighty humans with tiny probiotic Clostridium Butyricum: Probiotic Clostridium Butyricum CGMCC0313.1 may increase insulin sensitivity, slow down cardiac aging, and increase lifespan, via up-regulation of BubR1 and others longevity-promoting genes
From research findings to Therapeutic Opportunity:
This study suggests, for the first time, that Probiotic Clostridium Butyricum CGMCC0313.1, by increasing the expression of their target gene, they may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (fig. 1).
Figure 1. Probiotic Clostridium Butyricum CGMCC0313.1 may extend mammalian lifespan via up-regulation of BuBR1 and down-regulation of p70 S6 Kinase
Figure 2. Probiotic Clostridium Butyricum CGMCC0313.1 function as a longevity-promoting agent.
Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median lifespan. Thus, Probiotic Clostridium Butyricum CGMCC0313.1, either alone or in combination with other drugs,“ may be used to extend the lifespan of an individual (fig.2).
[easy_payment currency=”USD”]
Details on the research findings:
Idea Proposed/Formulated (with experimental evidence) by:
Dr L Boominathan Ph.D.
Amount: $75
0#
Undisclosed mechanistic information: How Probiotic Clostridium Butyricum CGMCC0313.1 increase the expression of BubR1 and extend mammalian life-span
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
# Research cooperation
References:
Web: http://genomediscovery.org or http://newbioideas.com
Citation: Boominathan, L., Lengthening the lifespan of mighty humans with tiny probiotic Clostridium Butyricum: Probiotic Clostridium Butyricum CGMCC0313.1 may increase insulin sensitivity, slow down cardiac aging, and increase lifespan, via up-regulation of BubR1 and others longevity-promoting genes, 28/October/2018, 11.00 pm, Genome-2-BioMedicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at admin@genomediscovery.org
